OTULIN and breast carcinoma: To further validate the role of OTULIN-mediated Wnt activation in promoting breast cancer drug resistance in vivo, we established orthotopic TNBC xenograft models with WT or OTULIN-KO MDA-MB-231 LM2 cells.